Zulvac 8 Bovis
inactivated bluetongue virus, serotype 8
Table of contents
Overview
The marketing authorisation for this product has been withdrawn at the request of the marketing authorisation holder.
Authorisation details
| Product details | |
|---|---|
| Name |
Zulvac 8 Bovis
|
| Agency product number |
EMEA/V/C/000145
|
| Active substance |
inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02
|
| International non-proprietary name (INN) or common name |
inactivated bluetongue virus, serotype 8
|
| Species |
Cattle
|
| Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI02AA08
|
| Publication details | |
|---|---|
| Marketing-authorisation holder |
Zoetis Belgium
|
| Revision |
7
|
| Date of issue of marketing authorisation valid throughout the European Union |
15/01/2010
|
| Contact address |
Zoetis Belgium |
Product information
23/03/2017 Zulvac 8 Bovis - EMEA/V/C/000145 - IG/0747
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Therapeutic indication
Active immunisation of cattle from three months of age for the prevention of viraemia caused by bluetongue virus, serotype 8.